This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with Montefiore Health System (MHS) to provide diagnostic laboratory services. This...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a rating of 100 from the Human Rights Campaign Foundation on the 2017...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostics information services, today announced that its Board of Directors elected Stephen H. Rusckowski, the company's President...
Quest Diagnostics Incorporated (NYSE: DGX) announced today that it is investigating an unauthorized third-party intrusion into an internet application on its network. The company provided notice...
Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care healthcare analytics technology, has been named the Most Innovative Product of...